Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Buy
100
PFGTF Quote, Financials, Valuation and Earnings
Last price:
$0.23
Seasonality move
:
6.56%
Day range:
$0.18 - $0.23
52-week range:
$0.02 - $0.23
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
19.89x
P/B ratio:
5.38x
Volume:
9.5K
Avg. volume:
1.9K
1-year change:
580.41%
Market cap:
$237.9M
Revenue:
$13M
EPS (TTM):
-$0.02
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
PFGTF
Pacific Edge Ltd.
|
-- | -- | -- | -- | -- |
|
ACAD
ACADIA Pharmaceuticals, Inc.
|
$292.5M | $0.14 | 13.44% | 28.72% | $31.21 |
|
AROAF
Aroa Biosurgery
|
-- | -- | -- | -- | -- |
|
FSPKF
Fisher & Paykel Healthcare Corp. Ltd.
|
-- | -- | -- | -- | -- |
|
RHCGF
Ryman Healthcare Ltd.
|
-- | -- | -- | -- | -- |
|
SMGRF
Summerset Group Holdings Ltd.
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
PFGTF
Pacific Edge Ltd.
|
$0.23 | -- | $237.9M | -- | $0.00 | 0% | 19.89x |
|
ACAD
ACADIA Pharmaceuticals, Inc.
|
$23.99 | $31.21 | $4.1B | 15.44x | $0.00 | 0% | 3.86x |
|
AROAF
Aroa Biosurgery
|
-- | -- | -- | -- | $0.00 | 0% | -- |
|
FSPKF
Fisher & Paykel Healthcare Corp. Ltd.
|
$22.10 | -- | $13B | 51.00x | $0.17 | 1.59% | 10.22x |
|
RHCGF
Ryman Healthcare Ltd.
|
$1.41 | -- | $705M | -- | $0.00 | 0% | 2.72x |
|
SMGRF
Summerset Group Holdings Ltd.
|
$6.97 | -- | $1.7B | 7.89x | $0.07 | 2.02% | 8.25x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
PFGTF
Pacific Edge Ltd.
|
1.14% | -4.632 | -- | 2.82x |
|
ACAD
ACADIA Pharmaceuticals, Inc.
|
5.64% | 2.900 | 1.52% | 2.70x |
|
AROAF
Aroa Biosurgery
|
-- | 0.000 | -- | -- |
|
FSPKF
Fisher & Paykel Healthcare Corp. Ltd.
|
3.28% | 1.642 | -- | 1.14x |
|
RHCGF
Ryman Healthcare Ltd.
|
-- | 2.214 | -- | -- |
|
SMGRF
Summerset Group Holdings Ltd.
|
36.6% | -0.062 | -- | 0.11x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
PFGTF
Pacific Edge Ltd.
|
-- | -- | -69.68% | -72.02% | -- | -- |
|
ACAD
ACADIA Pharmaceuticals, Inc.
|
$257M | $35.8M | 31.98% | 34.23% | 12.83% | $73.9M |
|
AROAF
Aroa Biosurgery
|
-- | -- | -- | -- | -- | -- |
|
FSPKF
Fisher & Paykel Healthcare Corp. Ltd.
|
$299.7M | -$209.7M | 18.6% | 19.71% | 40.18% | -- |
|
RHCGF
Ryman Healthcare Ltd.
|
-- | -- | -- | -- | -- | -- |
|
SMGRF
Summerset Group Holdings Ltd.
|
-- | -- | 5.8% | 12.83% | -- | -- |
Pacific Edge Ltd. vs. Competitors
-
Which has Higher Returns PFGTF or ACAD?
ACADIA Pharmaceuticals, Inc. has a net margin of -- compared to Pacific Edge Ltd.'s net margin of 25.76%. Pacific Edge Ltd.'s return on equity of -72.02% beat ACADIA Pharmaceuticals, Inc.'s return on equity of 34.23%.
Company Gross Margin Earnings Per Share Invested Capital PFGTFPacific Edge Ltd.-- -- $15.1M ACADACADIA Pharmaceuticals, Inc.92.23% $0.42 $972.1M -
What do Analysts Say About PFGTF or ACAD?
Pacific Edge Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand ACADIA Pharmaceuticals, Inc. has an analysts' consensus of $31.21 which suggests that it could grow by 30.1%. Given that ACADIA Pharmaceuticals, Inc. has higher upside potential than Pacific Edge Ltd., analysts believe ACADIA Pharmaceuticals, Inc. is more attractive than Pacific Edge Ltd..
Company Buy Ratings Hold Ratings Sell Ratings PFGTFPacific Edge Ltd.0 0 0 ACADACADIA Pharmaceuticals, Inc.9 6 1 -
Is PFGTF or ACAD More Risky?
Pacific Edge Ltd. has a beta of -3.385, which suggesting that the stock is 438.481% less volatile than S&P 500. In comparison ACADIA Pharmaceuticals, Inc. has a beta of 0.660, suggesting its less volatile than the S&P 500 by 33.951%.
-
Which is a Better Dividend Stock PFGTF or ACAD?
Pacific Edge Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. ACADIA Pharmaceuticals, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Pacific Edge Ltd. pays -- of its earnings as a dividend. ACADIA Pharmaceuticals, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PFGTF or ACAD?
Pacific Edge Ltd. quarterly revenues are --, which are smaller than ACADIA Pharmaceuticals, Inc. quarterly revenues of $278.6M. Pacific Edge Ltd.'s net income of -- is lower than ACADIA Pharmaceuticals, Inc.'s net income of $71.8M. Notably, Pacific Edge Ltd.'s price-to-earnings ratio is -- while ACADIA Pharmaceuticals, Inc.'s PE ratio is 15.44x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Pacific Edge Ltd. is 19.89x versus 3.86x for ACADIA Pharmaceuticals, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PFGTFPacific Edge Ltd.19.89x -- -- -- ACADACADIA Pharmaceuticals, Inc.3.86x 15.44x $278.6M $71.8M
-
Which has Higher Returns PFGTF or AROAF?
Aroa Biosurgery has a net margin of -- compared to Pacific Edge Ltd.'s net margin of --. Pacific Edge Ltd.'s return on equity of -72.02% beat Aroa Biosurgery's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital PFGTFPacific Edge Ltd.-- -- $15.1M AROAFAroa Biosurgery-- -- -- -
What do Analysts Say About PFGTF or AROAF?
Pacific Edge Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand Aroa Biosurgery has an analysts' consensus of -- which suggests that it could fall by --. Given that Pacific Edge Ltd. has higher upside potential than Aroa Biosurgery, analysts believe Pacific Edge Ltd. is more attractive than Aroa Biosurgery.
Company Buy Ratings Hold Ratings Sell Ratings PFGTFPacific Edge Ltd.0 0 0 AROAFAroa Biosurgery0 0 0 -
Is PFGTF or AROAF More Risky?
Pacific Edge Ltd. has a beta of -3.385, which suggesting that the stock is 438.481% less volatile than S&P 500. In comparison Aroa Biosurgery has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock PFGTF or AROAF?
Pacific Edge Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Aroa Biosurgery offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Pacific Edge Ltd. pays -- of its earnings as a dividend. Aroa Biosurgery pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PFGTF or AROAF?
Pacific Edge Ltd. quarterly revenues are --, which are smaller than Aroa Biosurgery quarterly revenues of --. Pacific Edge Ltd.'s net income of -- is lower than Aroa Biosurgery's net income of --. Notably, Pacific Edge Ltd.'s price-to-earnings ratio is -- while Aroa Biosurgery's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Pacific Edge Ltd. is 19.89x versus -- for Aroa Biosurgery. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PFGTFPacific Edge Ltd.19.89x -- -- -- AROAFAroa Biosurgery-- -- -- --
-
Which has Higher Returns PFGTF or FSPKF?
Fisher & Paykel Healthcare Corp. Ltd. has a net margin of -- compared to Pacific Edge Ltd.'s net margin of 29.46%. Pacific Edge Ltd.'s return on equity of -72.02% beat Fisher & Paykel Healthcare Corp. Ltd.'s return on equity of 19.71%.
Company Gross Margin Earnings Per Share Invested Capital PFGTFPacific Edge Ltd.-- -- $15.1M FSPKFFisher & Paykel Healthcare Corp. Ltd.41.41% $0.36 $1.1B -
What do Analysts Say About PFGTF or FSPKF?
Pacific Edge Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand Fisher & Paykel Healthcare Corp. Ltd. has an analysts' consensus of -- which suggests that it could fall by --. Given that Pacific Edge Ltd. has higher upside potential than Fisher & Paykel Healthcare Corp. Ltd., analysts believe Pacific Edge Ltd. is more attractive than Fisher & Paykel Healthcare Corp. Ltd..
Company Buy Ratings Hold Ratings Sell Ratings PFGTFPacific Edge Ltd.0 0 0 FSPKFFisher & Paykel Healthcare Corp. Ltd.0 0 0 -
Is PFGTF or FSPKF More Risky?
Pacific Edge Ltd. has a beta of -3.385, which suggesting that the stock is 438.481% less volatile than S&P 500. In comparison Fisher & Paykel Healthcare Corp. Ltd. has a beta of 1.237, suggesting its more volatile than the S&P 500 by 23.67%.
-
Which is a Better Dividend Stock PFGTF or FSPKF?
Pacific Edge Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Fisher & Paykel Healthcare Corp. Ltd. offers a yield of 1.59% to investors and pays a quarterly dividend of $0.17 per share. Pacific Edge Ltd. pays -- of its earnings as a dividend. Fisher & Paykel Healthcare Corp. Ltd. pays out 77.61% of its earnings as a dividend. Fisher & Paykel Healthcare Corp. Ltd.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios PFGTF or FSPKF?
Pacific Edge Ltd. quarterly revenues are --, which are smaller than Fisher & Paykel Healthcare Corp. Ltd. quarterly revenues of $723.8M. Pacific Edge Ltd.'s net income of -- is lower than Fisher & Paykel Healthcare Corp. Ltd.'s net income of $213.2M. Notably, Pacific Edge Ltd.'s price-to-earnings ratio is -- while Fisher & Paykel Healthcare Corp. Ltd.'s PE ratio is 51.00x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Pacific Edge Ltd. is 19.89x versus 10.22x for Fisher & Paykel Healthcare Corp. Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PFGTFPacific Edge Ltd.19.89x -- -- -- FSPKFFisher & Paykel Healthcare Corp. Ltd.10.22x 51.00x $723.8M $213.2M
-
Which has Higher Returns PFGTF or RHCGF?
Ryman Healthcare Ltd. has a net margin of -- compared to Pacific Edge Ltd.'s net margin of --. Pacific Edge Ltd.'s return on equity of -72.02% beat Ryman Healthcare Ltd.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital PFGTFPacific Edge Ltd.-- -- $15.1M RHCGFRyman Healthcare Ltd.-- -- -- -
What do Analysts Say About PFGTF or RHCGF?
Pacific Edge Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand Ryman Healthcare Ltd. has an analysts' consensus of -- which suggests that it could fall by --. Given that Pacific Edge Ltd. has higher upside potential than Ryman Healthcare Ltd., analysts believe Pacific Edge Ltd. is more attractive than Ryman Healthcare Ltd..
Company Buy Ratings Hold Ratings Sell Ratings PFGTFPacific Edge Ltd.0 0 0 RHCGFRyman Healthcare Ltd.0 0 0 -
Is PFGTF or RHCGF More Risky?
Pacific Edge Ltd. has a beta of -3.385, which suggesting that the stock is 438.481% less volatile than S&P 500. In comparison Ryman Healthcare Ltd. has a beta of 0.513, suggesting its less volatile than the S&P 500 by 48.743%.
-
Which is a Better Dividend Stock PFGTF or RHCGF?
Pacific Edge Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Ryman Healthcare Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Pacific Edge Ltd. pays -- of its earnings as a dividend. Ryman Healthcare Ltd. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PFGTF or RHCGF?
Pacific Edge Ltd. quarterly revenues are --, which are smaller than Ryman Healthcare Ltd. quarterly revenues of --. Pacific Edge Ltd.'s net income of -- is lower than Ryman Healthcare Ltd.'s net income of --. Notably, Pacific Edge Ltd.'s price-to-earnings ratio is -- while Ryman Healthcare Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Pacific Edge Ltd. is 19.89x versus 2.72x for Ryman Healthcare Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PFGTFPacific Edge Ltd.19.89x -- -- -- RHCGFRyman Healthcare Ltd.2.72x -- -- --
-
Which has Higher Returns PFGTF or SMGRF?
Summerset Group Holdings Ltd. has a net margin of -- compared to Pacific Edge Ltd.'s net margin of --. Pacific Edge Ltd.'s return on equity of -72.02% beat Summerset Group Holdings Ltd.'s return on equity of 12.83%.
Company Gross Margin Earnings Per Share Invested Capital PFGTFPacific Edge Ltd.-- -- $15.1M SMGRFSummerset Group Holdings Ltd.-- -- $2.6B -
What do Analysts Say About PFGTF or SMGRF?
Pacific Edge Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand Summerset Group Holdings Ltd. has an analysts' consensus of -- which suggests that it could fall by --. Given that Pacific Edge Ltd. has higher upside potential than Summerset Group Holdings Ltd., analysts believe Pacific Edge Ltd. is more attractive than Summerset Group Holdings Ltd..
Company Buy Ratings Hold Ratings Sell Ratings PFGTFPacific Edge Ltd.0 0 0 SMGRFSummerset Group Holdings Ltd.0 0 0 -
Is PFGTF or SMGRF More Risky?
Pacific Edge Ltd. has a beta of -3.385, which suggesting that the stock is 438.481% less volatile than S&P 500. In comparison Summerset Group Holdings Ltd. has a beta of -0.179, suggesting its less volatile than the S&P 500 by 117.891%.
-
Which is a Better Dividend Stock PFGTF or SMGRF?
Pacific Edge Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Summerset Group Holdings Ltd. offers a yield of 2.02% to investors and pays a quarterly dividend of $0.07 per share. Pacific Edge Ltd. pays -- of its earnings as a dividend. Summerset Group Holdings Ltd. pays out 16.94% of its earnings as a dividend. Summerset Group Holdings Ltd.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios PFGTF or SMGRF?
Pacific Edge Ltd. quarterly revenues are --, which are smaller than Summerset Group Holdings Ltd. quarterly revenues of --. Pacific Edge Ltd.'s net income of -- is lower than Summerset Group Holdings Ltd.'s net income of --. Notably, Pacific Edge Ltd.'s price-to-earnings ratio is -- while Summerset Group Holdings Ltd.'s PE ratio is 7.89x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Pacific Edge Ltd. is 19.89x versus 8.25x for Summerset Group Holdings Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PFGTFPacific Edge Ltd.19.89x -- -- -- SMGRFSummerset Group Holdings Ltd.8.25x 7.89x -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Sell
50
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 35x
Sell
40
Is GOOGL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 29x
Alerts
Buy
77
RNG alert for Feb 21
RingCentral, Inc. [RNG] is up 34.37% over the past day.
Sell
9
FROG alert for Feb 21
JFrog Ltd. [FROG] is down 24.98% over the past day.
Buy
72
SNSE alert for Feb 21
Sensei Biotherapeutics, Inc. [SNSE] is up 23.81% over the past day.
